| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8563414 | Complementary Therapies in Medicine | 2018 | 11 Pages |
Abstract
Available evidences indicate that Aidi injection can significantly improve the clinical response and OS rates in patients with NSCLC and especially, the 1- and 2-year OS rate. But, Aidi injection plus different therapies had different effects on overall survival. It is still unclear whether Aidi injection can improve the PFS and HR.
Keywords
VIPRCTsDCRBACEIL-2PRISMAQOLCNKIgemcitabine and cisplatinGCBORRCBMMSTAidi injectionQuality of lifePFsRandomized controlled trialsInterleukin-2Progression free survivalmedian survivaloverall survivalRisk differenceCochrane Central Register of Controlled TrialsRECISTRadiotherapyWorld Health OrganizationNon-small-cell lung cancer (NSCLC)NSCLCMeta-analysisCentralResponse Evaluation Criteria in Solid Tumorsobjective response rateDisease control ratenon-small-cell lung carcinomaWHO
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Zheng Xiao, Chengqiong Wang, Rui Zhou, Shanshan Hu, Nian Yi, Jihong Feng, Minghua Zhou, Shiyu Liu, Ling Chen, Jie Ding, Qihai Gong, Fushan Tang, Xiaofei Li,